Skip to main content
NASDAQ:CMLTU

CM Life Sciences III Competitors

$10.52
-0.17 (-1.59 %)
(As of 05/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.49
$11.00
50-Day Range N/A
52-Week Range
$10.49
$11.52
Volume213,287 shs
Average Volume150,215 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

CM Life Sciences III (NASDAQ:CMLTU) Vs. AFAQU, ANEB, ANZUU, ATSPU, ARRWU, and AUUD

Should you be buying CMLTU stock or one of its competitors? Companies in the industry of "--" are considered alternatives and competitors to CM Life Sciences III, including AF Acquisition (AFAQU), Anebulo Pharmaceuticals (ANEB), Anzu Special Acquisition Corp I (ANZUU), Archimedes Tech SPAC Partners (ATSPU), Arrowroot Acquisition (ARRWU), and Auddia (AUUD).

CM Life Sciences III (NASDAQ:CMLTU) and AF Acquisition (NASDAQ:AFAQU) are both -- companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

Valuation & Earnings

This table compares CM Life Sciences III and AF Acquisition's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CM Life Sciences IIIN/AN/AN/AN/AN/A
AF AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares CM Life Sciences III and AF Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CM Life Sciences IIIN/AN/AN/A
AF AcquisitionN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for CM Life Sciences III and AF Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CM Life Sciences III0000N/A
AF Acquisition0000N/A

Anebulo Pharmaceuticals (NASDAQ:ANEB) and CM Life Sciences III (NASDAQ:CMLTU) are both -- companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.

Earnings & Valuation

This table compares Anebulo Pharmaceuticals and CM Life Sciences III's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anebulo PharmaceuticalsN/AN/AN/AN/AN/A
CM Life Sciences IIIN/AN/AN/AN/AN/A

Profitability

This table compares Anebulo Pharmaceuticals and CM Life Sciences III's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Anebulo PharmaceuticalsN/AN/AN/A
CM Life Sciences IIIN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and price targets for Anebulo Pharmaceuticals and CM Life Sciences III, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Anebulo Pharmaceuticals0000N/A
CM Life Sciences III0000N/A

Anzu Special Acquisition Corp I (NASDAQ:ANZUU) and CM Life Sciences III (NASDAQ:CMLTU) are both -- companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, profitability and earnings.

Analyst Recommendations

This is a summary of recent ratings and target prices for Anzu Special Acquisition Corp I and CM Life Sciences III, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Anzu Special Acquisition Corp I0000N/A
CM Life Sciences III0000N/A

Earnings & Valuation

This table compares Anzu Special Acquisition Corp I and CM Life Sciences III's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A
CM Life Sciences IIIN/AN/AN/AN/AN/A

Profitability

This table compares Anzu Special Acquisition Corp I and CM Life Sciences III's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Anzu Special Acquisition Corp IN/AN/AN/A
CM Life Sciences IIIN/AN/AN/A

CM Life Sciences III (NASDAQ:CMLTU) and Archimedes Tech SPAC Partners (NASDAQ:ATSPU) are both -- companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations and earnings.

Valuation & Earnings

This table compares CM Life Sciences III and Archimedes Tech SPAC Partners' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CM Life Sciences IIIN/AN/AN/AN/AN/A
Archimedes Tech SPAC PartnersN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for CM Life Sciences III and Archimedes Tech SPAC Partners, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CM Life Sciences III0000N/A
Archimedes Tech SPAC Partners0000N/A

Profitability

This table compares CM Life Sciences III and Archimedes Tech SPAC Partners' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CM Life Sciences IIIN/AN/AN/A
Archimedes Tech SPAC PartnersN/AN/AN/A

CM Life Sciences III (NASDAQ:CMLTU) and Arrowroot Acquisition (NASDAQ:ARRWU) are both -- companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Profitability

This table compares CM Life Sciences III and Arrowroot Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CM Life Sciences IIIN/AN/AN/A
Arrowroot AcquisitionN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings for CM Life Sciences III and Arrowroot Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CM Life Sciences III0000N/A
Arrowroot Acquisition0000N/A

Earnings and Valuation

This table compares CM Life Sciences III and Arrowroot Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CM Life Sciences IIIN/AN/AN/AN/AN/A
Arrowroot AcquisitionN/AN/AN/AN/AN/A

Auddia (NASDAQ:AUUD) and CM Life Sciences III (NASDAQ:CMLTU) are both -- companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, institutional ownership, risk, dividends and earnings.

Profitability

This table compares Auddia and CM Life Sciences III's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AuddiaN/AN/AN/A
CM Life Sciences IIIN/AN/AN/A

Valuation and Earnings

This table compares Auddia and CM Life Sciences III's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AuddiaN/AN/AN/AN/AN/A
CM Life Sciences IIIN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations for Auddia and CM Life Sciences III, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Auddia0000N/A
CM Life Sciences III0000N/A


CM Life Sciences III Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
AFAQU
AF Acquisition
0.0$9.95-0.5%$0.00N/A0.00
ANEB
Anebulo Pharmaceuticals
0.0$7.00-0.0%$0.00N/A0.00
ANZUU
Anzu Special Acquisition Corp I
0.0$9.98-0.2%$0.00N/A0.00
ATSPU
Archimedes Tech SPAC Partners
0.0$9.98-0.2%$0.00N/A0.00
ARRWU
Arrowroot Acquisition
0.0$9.99-0.1%$0.00N/A0.00
AUUD
Auddia
0.0$2.42-0.8%$0.00N/A0.00
BRIVU
B. Riley Principal 250 Merger Corp. Units
0.0$9.99-0.1%$0.00N/A0.00
BSA
BrightSphere Investment Group
0.0$25.20-0.3%$0.00N/A0.00
CPZ
Calamos Long/Short Equity & Dynamic Income Term Trust
0.0$20.36-0.3%$0.00N/A0.00
CRZNU
Corazon Capital V838 Monoceros
0.0$9.98-0.2%$0.00N/A0.00
DKDCU
Data Knights Acquisition Corp. Unit
0.0$10.09-0.0%$0.00N/A0.00
DCRCU
Decarbonization Plus Acquisition Corp III
0.0$9.96-0.4%$0.00N/A0.00
DLY
DoubleLine Yield Opportunities Fund
0.0$19.66-0.1%$0.00N/A0.00
EBACU
European Biotech Acquisition
0.0$10.00-0.5%$0.00N/A0.00
EVOJ
Evo Acquisition
0.3$9.77-0.0%$0.00N/A0.00
FRSGU
First Reserve Sustainable Growth
0.0$9.99-0.0%$0.00N/A0.00
FMIVU
Forum Merger IV
0.0$9.96-0.0%$0.00N/A0.00
FRONU
Frontier Acquisition
0.0$10.08-0.3%$0.00N/A0.00
HERAU
FTAC Hera Acquisition
0.0$9.99-0.1%$0.00N/A0.00
GLHAU
Glass Houses Acquisition
0.0$10.00-0.3%$0.00N/A0.00
GLSPU
Global SPAC Partners
0.0$10.00-0.2%$0.00N/A0.00Quiet Period Expiration
GMLPP
Golar LNG Partners LP 8.75% CUM PFD A
0.8$23.25-0.7%$0.00N/A0.00
GAMCU
Golden Arrow Merger
0.0$9.95-0.2%$0.00N/A0.00
GBRGU
Goldenbridge Acquisition
0.0$10.45-0.0%$0.00N/A0.00
GSEVU
Gores Holdings VII
0.0$10.00-0.1%$0.00N/A0.00
HGLB
Highland Global Allocation Fund
0.3$8.67-1.3%$0.00N/A0.00
IPVIU
InterPrivate IV InfraTech Partners
0.0$10.00-0.3%$0.00N/A0.00
ISLEU
Isleworth Healthcare Acquisition
0.0$9.90-0.0%$0.00N/A0.00
KSICU
Kadem Sustainable Impact
0.0$9.98-0.1%$0.00N/A0.00
LCAAU
L Catterton Asia Acquisition
0.0$10.03-0.3%$0.00N/A0.00
LEGAU
Lead Edge Growth Opportunities
0.0$9.97-0.1%$0.00N/A0.00
LVRAU
Levere
0.0$10.01-0.0%$0.00N/A0.00
LEV
Lion Electric
1.7$15.03-5.0%$0.00N/A0.00Analyst Revision
MHNC
Maiden Holdings North America
0.8$23.67-1.1%$0.00N/A0.00
MAQCU
Maquia Capital Acquisition Co. Unit
0.0$10.00-0.2%$0.00N/A0.00
NMCO
Nuveen Municipal Credit Opportunities Fund
0.0$14.88-0.4%$0.00N/A0.00
PIMCO Energy and Tactical Credit Opportunities Fund logo
NRGX
PIMCO Energy and Tactical Credit Opportunities Fund
0.8$11.10-0.1%$0.00N/A0.00Insider Buying
PYT
PPLUS Trust Series GSC-2 GSC 2 CT FL RT
0.4$24.00-0.0%$0.00N/A0.00Dividend Cut
News Coverage
FRWAU
PWP Forward Acquisition Corp. I
0.0$10.00-0.0%$0.00N/A0.00
RTPYU
Reinvent Technology Partners Y
0.0$10.07-0.1%$0.00N/A0.00
RXRAU
RXR Acquisition
0.0$9.99-0.0%$0.00N/A0.00
SPKBU
Silver Spike Acquisition Corp II
0.0$10.00-0.1%$0.00N/A0.00
SBEAU
SilverBox Engaged Merger Corp I
0.0$9.98-0.2%$0.00N/A0.00
SRNGU
Soaring Eagle Acquisition
0.0$10.25-0.1%$0.00N/A0.00
TALS
Talaris Therapeutics
0.3$14.37-9.2%$0.00N/A0.00Insider Buying
TBSAU
TB SA Acquisition
0.0$9.95-0.0%$0.00N/A0.00
TCVA
TCV Acquisition
0.0$10.02-1.3%$0.00N/A0.00
TEAF
Tortoise Essential Assets Income Term Fund
0.9$14.23-0.1%$0.00N/A0.00Dividend Announcement
News Coverage
TravelCenters of America LLC 8% SR NT 2030 logo
TANNZ
TravelCenters of America LLC 8% SR NT 2030
0.7$25.82-0.5%$0.00N/A0.00
TravelCenters of America LLC SR NT logo
TANNL
TravelCenters of America LLC SR NT
0.5$25.87-1.1%$0.00N/A0.00
This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.